MyAverix Finance
HK · Healthcare
PegBio Co Ltd (2565)
Biotechnology
PegBio Co Ltd (2565) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $4.98B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2565
PegBio Co Ltd (2565) — FAQ
What is PegBio Co Ltd's market cap?
PegBio Co Ltd (2565) has a reported market cap of $4.98B (data as of 2026-05-21).
What is 2565's P/E ratio?
The price-to-earnings (P/E) ratio for PegBio Co Ltd (2565) is 18.00 (data as of 2026-05-21).
Does PegBio Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for PegBio Co Ltd (2565). Check the MyAverix Finance app for the latest dividend data.
What sector is PegBio Co Ltd in?
PegBio Co Ltd (2565) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2565 listed on?
2565 is listed on HK.
What is PegBio Co Ltd's net margin?
PegBio Co Ltd (2565) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.